Full Contents >>
New IP round-up from @mdloney, featuring biosimilars complaint, SiriusXM ruling, ED of Tex filing slump and more! https://t.co/1szaMeR3j1
Our analysis of SCOTUS Life Tech v Promega ruling https://t.co/CL6Ibt23RO Court didn't indicate how many components enough for infringement
RT @PatentScholar: SCOTUS opinion in LifeTech v. Promega is out—supply of single component doesn't lead to §271(f)(1) liability https://t.c…
Top firms for trade marks 2017
Find out which firms are ranked in the first part of this year’s IP Stars research. Below, we provide a guide to the research and methodology
The material on this site is for financial institutions, professional investors
and their professional advisers. It is for information only. Please read our
Terms and Conditions
before using the site. All material subject to strictly enforced copyright laws.
© 2017 Euromoney Institutional Investor PLC. For help please
see our FAQ.
Switching to MIP International